A detailed history of Invesco Ltd. transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 154,602 shares of IDYA stock, worth $4.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
154,602
Previous 129,924 18.99%
Holding current value
$4.17 Million
Previous $4.56 Million 7.37%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$30.37 - $43.05 $749,470 - $1.06 Million
24,678 Added 18.99%
154,602 $4.9 Million
Q2 2024

Aug 13, 2024

SELL
$34.37 - $43.46 $5.8 Million - $7.33 Million
-168,769 Reduced 56.5%
129,924 $4.56 Million
Q1 2024

May 14, 2024

BUY
$34.2 - $47.13 $2.77 Million - $3.82 Million
80,965 Added 37.19%
298,693 $13.1 Million
Q4 2023

Feb 12, 2024

SELL
$24.59 - $35.83 $1.78 Million - $2.6 Million
-72,539 Reduced 24.99%
217,728 $7.75 Million
Q3 2023

Nov 13, 2023

BUY
$21.07 - $29.77 $1.29 Million - $1.82 Million
61,157 Added 26.69%
290,267 $7.83 Million
Q2 2023

Aug 11, 2023

BUY
$13.33 - $25.53 $2.8 Million - $5.36 Million
209,794 Added 1086.12%
229,110 $5.38 Million
Q1 2023

May 12, 2023

SELL
$13.49 - $18.72 $1.21 Million - $1.68 Million
-89,837 Reduced 82.3%
19,316 $265,000
Q4 2022

Feb 13, 2023

BUY
$14.47 - $18.17 $1.4 Million - $1.76 Million
96,690 Added 775.82%
109,153 $1.98 Million
Q3 2022

Nov 14, 2022

SELL
$9.24 - $15.79 $628 - $1,073
-68 Reduced 0.54%
12,463 $185,000
Q2 2022

Aug 15, 2022

SELL
$8.28 - $13.88 $1,978 - $3,317
-239 Reduced 1.87%
12,531 $173,000
Q1 2022

May 16, 2022

BUY
$11.18 - $24.02 $816 - $1,753
73 Added 0.57%
12,770 $143,000
Q4 2021

Feb 14, 2022

SELL
$20.95 - $26.88 $4.81 Million - $6.17 Million
-229,485 Reduced 94.76%
12,697 $300,000
Q3 2021

Nov 15, 2021

BUY
$17.26 - $27.08 $4.18 Million - $6.56 Million
242,182 New
242,182 $6.17 Million

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.3B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.